prednisone has been researched along with maytansine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aboukameel, A; Al-Katib, AM; Bissery, MC; Mohammad, R; Zuany-Amorim, C | 1 |
| Carrigan, CN; Chicklas, S; Chittenden, T; Deckert, J; Erickson, HK; Lai, KC; Lambert, JM; Li, M; Lutz, RJ; Mayo, MF; Park, PU; Pinkas, J; Yi, Y | 1 |
2 other study(ies) available for prednisone and maytansine
| Article | Year |
|---|---|
Superior antitumor activity of SAR3419 to rituximab in xenograft models for non-Hodgkin's lymphoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cyclophosphamide; Doxorubicin; Humans; Immunoconjugates; Immunologic Factors; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Maytansine; Mice; Mice, SCID; Prednisone; Rituximab; Vincristine; Xenograft Model Antitumor Assays | 2009 |
A novel anti-CD37 antibody-drug conjugate with multiple anti-tumor mechanisms for the treatment of B-cell malignancies.
Topics: Animals; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; B-Lymphocytes; Bendamustine Hydrochloride; Cell Line, Tumor; Cyclophosphamide; Cytotoxicity, Immunologic; Drug Screening Assays, Antitumor; Female; Humans; Immunotoxins; Maytansine; Mice; Mice, SCID; Molecular Targeted Therapy; Nitrogen Mustard Compounds; Prednisone; Rituximab; Tetraspanins; Vincristine; Xenograft Model Antitumor Assays | 2013 |